Publisher： Karger
E-ISSN： 1424-8840|32|3|39-45
ISSN： 1424-8832
Source： Pathophysiology of Haemostasis and Thrombosis, Vol.32, Iss.3, 2003-06, pp. : 39-45
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
An Overview of the Direct Thrombin Inhibitor Argatroban
Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 3, 2003-06 ,pp. :
Access to resources
Recommend
Practical Issues in the Development of Argatroban: A Perspective
Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 3, 2003-06 ,pp. :
Development of Argatroban as an Anticoagulant and Antithrombin Agent in Japan
Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 3, 2003-06 ,pp. :
Argatroban in HIT Type II and Acute Coronary Syndrome
Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 3, 2003-06 ,pp. :
Argatroban Anticoagulation in Renal Dysfunction: A Literature Analysis
Nephron Clin Pract, Vol. 109, Iss. 2, 2008-06 ,pp. :